Clinical Trials Browser

Phase 3 × Breast Neoplasms × Rosuvastatin Calcium × Clear all

NCT05338723 2024-02-28

Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients

Phase 3 Completed

Breast Neoplasms